Study of the Blood Concentrations of Two Formulations of REGN1033 in Healthy Subjects

NCT02741739 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
28
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Regeneron Pharmaceuticals